View Clinical Trial (Medical Research Study)
Efficacy of a Needling Device for the Treatment of Acne Scars - NCT00974870-60611(Clinical Trial 320051)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Chicago |
|
State:
|
|
IL |
| Zip Code: |
|
60611 |
| Conditions: |
|
Acne Scars |
| Purpose: |
|
The primary objective of this study is to determine the efficacy of a needling device for
treatment of acne scars.
|
| Study summary: |
|
We are investigating a needled micro-roller for use in improving the appearance of acne
scars. The study is being conducted under the direction of Dr. Murad Alam of Northwestern
University, Department of Dermatology.
The needles on the micro-roller are designed to create small holes in the top and mid layers
of skin in order to induce the formation of more collagen, which would in turn help improve
the appearance of acne scars. To qualify for the study, you must have at least 2 large areas
of the face with acne scars.
The study is designed such that one part of your face, which has acne scars, will be treated
with the device on 3 separate occasions, spaced 2 weeks apart at our clinic in Chicago at
Northwestern. We would also ask you to return at 3 months and at 6 months to have
photographs taken.
If you are interested in participating, we would like to get you involved as soon as
possible |
| Criteria: |
|
Inclusion Criteria:
- Ages 18-70 years old
- Subjects in general good health
- The subject has the willingness and the ability to understand and provide informed
consent for the use of their tissue and communicate with the investigator
- Global Acne Scarring Classification grade 2-41 (Appendix II)
- Subject has at least two areas of acne scaring on the face (with at least 2 acne
scars in each) that are at least 2 cm apart
Exclusion Criteria:
- Pregnancy and lactation
- Subjects with history of keloid or hypertrophic scars
- Subjects with active skin disease (other than mild acne) or skin infection in the
treatment area
- Subjects with an active systematic or local skin disease that is likely to alter
wound healing
- Subjects who have undergone in the past 6 months or planning to undergo in the next 6
months the following cosmetic treatments in the acne scar area
- Injectable permanent filler
- Ablative laser treatment
- Subjects taking the following prescription medications:
- Accutane or other retinoids within the past 12 months
- Anticoagulant (warfarin)
- Subjects who allergic to lidocaine and prilocaine |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
February 2, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|